Quek, L., David, M. D., Kennedy, A., Metzner, M., Amatangelo, M., Shih, A., . . . Vyas, P. (2018). Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor Enasidenib. Nat Med.
Chicago Style aipamenaQuek, Lynn, et al. "Clonal Heterogeneity of Acute Myeloid Leukemia Treated With the IDH2 Inhibitor Enasidenib." Nat Med 2018.
MLA aipamenaQuek, Lynn, et al. "Clonal Heterogeneity of Acute Myeloid Leukemia Treated With the IDH2 Inhibitor Enasidenib." Nat Med 2018.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.